The first case of human systemic infection by an Aspergillus flavus is
olate demonstrated to produce aflatoxins in vitro and in vivo is descr
ibed. The patient, a 41-year-old man with acute myelogenous leukaemia,
developed a complication of suspected pulmonary Aspergillus infection
during remission induction therapy. Antifungal chemotherapy brought a
bout a considerable degree of improvement, but remission of the underl
ying disease was not attained.:Bone marrow transplantation was also no
t effective. The patient showed recovery from neutropenia but died des
pite aggresive antifungal chemotherapy. The autopsy revealed lesions i
n the lungs, myocardium, kidneys, brain, thyroid gland and skin due to
a suspected Aspergillus sp. A fungus isolated from the right lung and
the skin lesions was identified as A. flavus. Aflatoxins B-1, B-2 and
M-1 were detected in culture filtrates of the isolated A. fluvus, and
in an extract of lung lesions. These aflatoxins are considered to hav
e played an important role in damaging the immune system of the patien
t through their toxic effects.